71 West Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
71 West Capital Partners's BMY Position: Q2 2026 in Review
71 West Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 50% in Q2 2026, buying an estimated $321K and bringing the position to 16,821 shares worth $969K. The position accounts for 0.03% of the portfolio, ranked #142.
71 West Capital Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- 71 West Capital Partners held 16,821 shares of Bristol-Myers Squibb worth $969K as of Q2 2026.
- 71 West Capital Partners bought 5,586 Bristol-Myers Squibb shares in Q2 2026, an estimated $321K.
- Bristol-Myers Squibb made up 0.03% of 71 West Capital Partners's portfolio in Q2 2026, its #142 holding.
- 71 West Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on 71 West Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.